Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Current Assets: 2023-2024

Historic Current Assets for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to $479.2 million.

  • Upstream Bio's Current Assets rose 71.17% to $389.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $389.0 million, marking a year-over-year increase of 71.17%. This contributed to the annual value of $479.2 million for FY2024, which is 309.55% up from last year.
  • Upstream Bio's Current Assets amounted to $479.2 million in FY2024, which was up 309.55% from $117.0 million recorded in FY2023.
  • Upstream Bio's Current Assets' 5-year high stood at $479.2 million during FY2024, with a 5-year trough of $117.0 million in FY2023.
  • Moreover, its 2-year median value for Current Assets was $298.1 million (2023), whereas its average is $298.1 million.
  • Data for Upstream Bio's Current Assets shows a peak YoY skyrocketed of 309.55% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Upstream Bio's Current Assets stood at $117.0 million in 2023, then soared by 309.55% to $479.2 million in 2024.